scholarly article | Q13442814 |
P356 | DOI | 10.1086/651599 |
P8608 | Fatcat ID | release_zg7mhtcuqvbd7atplkudyj3j3i |
P932 | PMC publication ID | 3860186 |
P698 | PubMed publication ID | 20235831 |
P5875 | ResearchGate publication ID | 42253893 |
P50 | author | Hanno Ulmer | Q47865044 |
Georg M Lauer | Q60976715 | ||
Carlos A Fernandes | Q83176799 | ||
P2093 | author name string | Karl P Pfeiffer | |
Arthur Y Kim | |||
Julian Schulze Zur Wiesch | |||
Marcelo Alves Pinto | |||
Clara Fumiko Tachibana Yoshida | |||
Elisabeth Lampe | |||
Jaqueline Mendes de Oliveira | |||
Georg Goebel | |||
Lia L Lewis-Ximenez | |||
João Luiz Pereira | |||
Alexander M Strasak | |||
Cleber F Ginuino | |||
Gláucia Paranhos-Baccalá | |||
Paulo Sergio Fonseca de Sousa | |||
Adilson José Almeida | |||
Carlos Eduardo Velloso | |||
Henrique Sergio Coelho | |||
P2860 | cites work | Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion? | Q42988404 |
Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test | Q42993351 | ||
Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users | Q43000196 | ||
Quantitation of HCV RNA using real-time PCR and fluorimetry | Q43031765 | ||
Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. | Q43032166 | ||
Virus-specific antibody titres in different phases of hepatitis C virus infection | Q43040987 | ||
Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load | Q43041574 | ||
Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance | Q43042132 | ||
Intrafamilial transmission of hepatitis C virus infection | Q45416910 | ||
Limited humoral immunity in hepatitis C virus infection | Q45752127 | ||
Natural course of acute hepatitis C: a long-term prospective study | Q47912531 | ||
Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. | Q50582782 | ||
Acute hepatitis C | Q73427444 | ||
Natural history of hepatitis C | Q80384219 | ||
Outcomes and Treatment of Acute Hepatitis C Virus Infection in a United States Population | Q27478177 | ||
Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non genotype 1 infection | Q27481055 | ||
Acute hepatitis C virus infection: A chronic problem | Q27485639 | ||
Improving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria | Q27489594 | ||
Global epidemiology of hepatitis C virus infection | Q27860799 | ||
A comparative review of HLA associations with hepatitis B and C viral infections across global populations | Q28299722 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C | Q29620614 | ||
Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a | Q33396464 | ||
Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection | Q33650138 | ||
Prospective evaluation of community-acquired acute-phase hepatitis C virus infection | Q33986385 | ||
Humoral immune response in acute hepatitis C virus infection | Q33989160 | ||
Acute hepatitis C. | Q34013032 | ||
Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002. | Q35105731 | ||
Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. | Q35595775 | ||
Global burden of disease (GBD) for hepatitis C. | Q35610002 | ||
Host genetic determinants in hepatitis C virus infection | Q35753723 | ||
Neutralizing antibody response during acute and chronic hepatitis C virus infection | Q35971609 | ||
Acute hepatitis C: a multifaceted disease | Q36054683 | ||
Acute hepatitis C: diagnosis and management. | Q36074803 | ||
Acute hepatitis C virus infection | Q36304396 | ||
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies | Q36346436 | ||
Acute hepatitis C: a systematic review | Q37162708 | ||
Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees | Q37502673 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Brazil | Q155 |
hepatitis C | Q154869 | ||
Hepatitis C virus | Q708693 | ||
P304 | page(s) | 1222-1230 | |
P577 | publication date | 2010-05-01 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Prospective follow-up of patients with acute hepatitis C virus infection in Brazil | |
P478 | volume | 50 |
Q35783526 | An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells |
Q33791343 | Antibody dynamics and spontaneous viral clearance in patients with acute hepatitis C infection in Rio de Janeiro, Brazil. |
Q34417123 | Association of IL-10, IL-4, and IL-28B gene polymorphisms with spontaneous clearance of hepatitis C virus in a population from Rio de Janeiro |
Q39715964 | Clinical epidemiology of acute hepatitis C in South America. |
Q41546485 | Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first? |
Q38020158 | Laboratory diagnostics for hepatitis C virus infection |
Q34779758 | Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection |
Q38984477 | Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward |
Q37111632 | Role of IL28B gene polymorphism and cell-mediated immunity in spontaneous resolution of acute hepatitis C. |
Q35899199 | Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution |
Q28476680 | The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population study |
Q36538481 | The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia |
Search more.